U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT03761797) titled 'A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes' on Nov. 30, 2018.
Brief Summary: Study objectives is to investigate the safety of long-term daily use of TRADIANCE(R) Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.
Study Type: Observational
Condition: Diabetes Mellitus, Type 2
Intervention: * Drug: TRADIANCE(R) Combination Tablets AP
Fixed dose combination
* Drug: TRADIANCE(R) Combination Tablets BP
Fixed dose combination
Recruitment Status: Recruiting
Sponsor: Boehringer Ingelheim
Information provided by (Responsible ...